Biogen Inc.BIIBNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -59.76% |
| Q3 2025 | 690.86% |
| Q2 2025 | -37.95% |
| Q1 2025 | -65.92% |
| Q4 2024 | -18.67% |
| Q3 2024 | 49.50% |
| Q2 2024 | 13.12% |
| Q1 2024 | 4325.60% |
| Q4 2023 | -97.89% |
| Q3 2023 | 21.64% |
| Q2 2023 | 6.96% |
| Q1 2023 | 360.17% |
| Q4 2022 | -126.48% |
| Q3 2022 | -10.25% |
| Q2 2022 | 355.19% |
| Q1 2022 | -80.70% |
| Q4 2021 | 4.10% |
| Q3 2021 | -34.38% |
| Q2 2021 | 59.60% |
| Q1 2021 | 309.48% |
| Q4 2020 | -131.08% |
| Q3 2020 | -39.38% |
| Q2 2020 | 32.79% |
| Q1 2020 | -25.15% |
| Q4 2019 | 15.65% |
| Q3 2019 | -13.70% |
| Q2 2019 | 34.57% |
| Q1 2019 | -23.00% |
| Q4 2018 | 9.19% |
| Q3 2018 | 57.91% |
| Q2 2018 | -24.56% |
| Q1 2018 | -4.03% |
| Q4 2017 | -6.76% |
| Q3 2017 | 39.27% |
| Q2 2017 | 397.11% |
| Q1 2017 | -85.08% |
| Q4 2016 | 59.80% |
| Q3 2016 | -0.92% |
| Q2 2016 | 3.36% |
| Q1 2016 | -7.40% |